Hong Truong

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial”.

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.01485

N/A

3.3DataRank · unranked

100 citations

Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo +34 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0.604DataRank · unranked

55 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0.416DataRank · unranked

15 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.418

N/A

0.165DataRank · unranked

2 citations

Rania Sheikh, Aliya Khurram, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz +10 more

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5007

N/A

0DataRank · unranked

4 citations

Vignesh Ravichandran, Yelena Kemel, Andrea Knežević, Jack P. Gleeson, Nicole Benfante +12 more

Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.523

N/A

0DataRank · unranked

2 citations

Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter A. Reisz +15 more

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.06.010

N/A

0DataRank · unranked

1 citations

Hong Truong, Song Jiang, Paul K-Lee, Benjamin Davelman, Danielle Gordon +8 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Development and validation of a preliminary multivariable diagnostic model for identifying unusual infections in hospitalized patients

Biomolecules and Biomedicine(2024)10.17305/bb.2024.10447

N/A

0DataRank · unranked

7 citations

Mohammad Joghataee, Lucrezia Rovati, Hong Truong, Claudia Castillo Zambrano, Kushagra Kushagra +8 more

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

European Urology Oncology(2021)10.1016/j.euo.2021.09.005

N/A

0DataRank · unranked

39 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Peter A. Reisz, Andrew T. Lenis +22 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0DataRank · unranked

4 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Genomic characterization of bladder cancer with variant histology.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.470

N/A

0DataRank · unranked

2 citations

Timothy N. Clinton, Wenhuo Hu, Nima Almassi, Peter A. Reisz, Hong Truong +12 more

Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5022

N/A

0DataRank · unranked

1 citations

Kelsey Breen, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz, Nicole Benfante +15 more

Evaluation of germline genetic testing criteria in early-onset kidney cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.296

N/A

0DataRank · unranked

0 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Aliya Khurram, Peter A. Reisz +15 more